Drugs / RIMACALIB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00296257 | Feb 2006 → Apr 2008 | rheumatoid arthritis | Dainippon Sumitomo Pharma Europe LTd. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RIMACALIB | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107772 ↗ |
| Known as | SMP-114 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00296257 ↗ |
| Modality | Small molecule | — CHEMBL2107772 ↗ |